Brooke Coburn is a Geneseo, New York based female eyecare provider who is specialized as Optician. Active license number of Brooke Coburn is 010265 for Optician in New York. Brooke Coburn makes / sells eyeglasses and, contact lenses, for remedying defects of vision in accordance with the prescriptions of ophthalmologists and optometrists. Opticians also specializes in filling lens prescriptions, assisting patients with lens and frame selection and fitting (including style, weight and colour) but they do not test vision or write prescriptions for visual correction.
Complete Profile:
Brooke Coburn speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Optician
Gender:
Female
Practice Address:
48 E South St Ste 110, Geneseo, New York, 14454-1390
Phone:
585-602-2130
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1962391276
NPI Enumeration Date:
01 Jul, 2025
NPI Last Update On:
01 Jul, 2025
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Brooke Coburn are as mentioned below.
License Number
Specialization
State
Status
010265
Optician
New York
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
48 E South St Ste 110, Geneseo, New York
Zip:
14454-1390
Phone Number:
--
Fax Number:
--
Patients can reach Brooke Coburn at 48 E South St Ste 110, Geneseo, New York or can call to book an appointment on 585-602-2130. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 July, 2025.